3D Ultrasound to Assess in Recurrent Miscarriage
- Conditions
- Recurrent Miscarriage
- Interventions
- Diagnostic Test: 3D Ultrasound scan with power Doppler angiography
- Registration Number
- NCT06164015
- Brief Summary
This observational study aims to compare the prevalence of acquired abnormalities of the uterus (fibroids, polyps, intrauterine adhesions, adenomyosis) in women who have recurrent miscarriages with the fertile population.
- Detailed Description
High-quality studies including several meta-analyses have proven the association between congenital uterine anomalies and recurrent miscarriages. Nevertheless, there are limited studies evaluating the impact of acquired uterine anomalies on recurrent miscarriages.
This prospective observational study will aim to compare the prevalence of acquired uterine anomalies between the study group and the control group. The secondary aim will be to compare the Endometrial morphological features like endometrial volume, endometrial and sub-endometrial vascularity between the two groups
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 400
- Women between the age group of 18-40 years
- Women who have had 2 or more pregnancy losses before 24 weeks of gestation - Study group.
- Women who can provide documented informed consent
- Women with proven fertility with at least one child - Control group
- Women with previous history of miscarriage/ extreme preterm delivery (before 28 weeks of gestation) will be excluded from the Control group.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Recurrent Miscarriage group (study group) 3D Ultrasound scan with power Doppler angiography Group of women who have experienced 2 or more pregnancy loss of less than 24 weeks gestation. Fertile population group (control group) 3D Ultrasound scan with power Doppler angiography Group of women with proven fertility with at least one child born at full term
- Primary Outcome Measures
Name Time Method Prevalence of Acquired Uterine Anomalies 24 months Primary outcome will be to compare the prevalence of acquired uterine anomalies (estimated as the proportion of anomalies diagnosed on 3D pelvic ultrasound) between study group and control group
- Secondary Outcome Measures
Name Time Method Endometrial volume 24 months measured by 3D ultrasound (in ml)
Endometrial thickness 24 months measured by ultrasound (in mm)
Endometrial blood flow indices (vascularisation index, flow index and vascularisation flow index) 24 months All three indices as measured by 3D ultrasound using VOCAL software